Program overview
Context
Indication: Medulloblastoma
Mechanism: Unknown
Modality: Unknown
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Sonidegib is flagged as registry stop signal because public records show a registry stop signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Medulloblastoma
Mechanism: Unknown
Modality: Unknown
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Registry: 5/5
Timeline: 0/5
Recruitment burden: 1/5
Results availability: 0/5
Program risk: 3/5
https://clinicaltrials.gov/study/NCT04402073
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT04402073 | Registry Stop Signal (TERMINATED) | None | Low Signal | rare_population_signal |